Neudle.com: Parkinson disease progression

Neurology Specific Literature Search

Differential
(Click to cross reference)

adolescent medicine

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

alien hand syndrome

alpha-synuclein

aphasia, progressive, primary

apraxia, constructional

ataxia, cerebellar

ataxia, progressive

auditory and vestibular pathways

autoimmune cerebellar ataxia

autoimmune disease

autonomic cardiovascular reflexes

autonomic dysfunction

axonal degeneration

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

biologic markers

blinking, reduced

carbon monoxide poisoning

CAT scan, emission, abnormal

cavernous hemangioma

central hypoventilation

cerebellar ataxia, neuropathy and vestibular areflexia syndrome

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar edema

cerebellar lesion

cerebellum, disease of

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction

cerebrospinal fluid, elevated protein of

cerebrovascular accident

cerebrovascular accident, nonarterial territory

chromosomal abnormality

cingulate island sign

Clinical Pathologic Conference(C.P.C.)

coat-hanger pain

computers, medicine and

contractures, joint

controversies in neurology

corpus callosum, thinning

cortical blindness

cortical infarction

cortical-basal ganglionic degeneration

degenerative diseases of CNS

delay in diagnosis

dementia, age at onset

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, presenile

dementia, rapidly progressive

developmental milestones, loss of

developmental retardation

dexterity, impaired

diabetes mellitus

diagnostic criteria

differential diagnosis

distal muscle atrophy

diurnal variation

dopa responsive dystonia

dopamine agonist

drug induced neurologic disorders

dysdiadochokinesia

dystonia, cervical

dystonia, children

encephalitis, episodic

encephalitis, Powassan

encephalitis, viral

encephalopathy, delayed

encephalopathy, progressive

epidemiology of neurology

erectile dysfunction

evidence-based research

executive dysfunction

exome sequencing

eye movement, disorders of

failure to thrive

fourth ventricle, compression

frontal behavioral spatial syndrome

frontotemporal dementia, behavioral variant

gammaglobulin therapy, intravenous

gaze palsy, horizontal

gaze palsy, supranuclear

gaze palsy, vertical

genetic counselling

genetic neurologic disorders

genetic screening

genetic testing

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

glutamic acid decarboxylase, antibody

Hallervorden Spatz disease

hemangioma, brainstem

hemifacial spasm

hepatic failure

hepatolenticular degeneration, non-Wilsonian

hepatosplenomegaly

hyperammonemic encephalopathy

hypotension, neurologic causes of

hypotension, systemic

iatrogenic neurologic disorders

imbalance, postural

immunomodulation

inclusion bodies

inclusion bodies, intranuclear

incontinence, fecal

inflexibility, mental

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

Jakob-Creutzfeldt disease

leg spasms, painful

lenticular nucleus, lesion of, bilateral

leukoencephalopathy

level of consciousness, decreased

Lewy body disease, diffuse

life expectancy

loss of sympathy

malformation, vascular

malformation, vascular, cerebral

marche a petits pas

memory, defect of recent

memory, impairment of

meningeal enhancement

meningoencephalitis

mental status, abnormal

migratory lesion pattern

mitochondrial disease

motor neuron disease

movement disorder

movement disorder, drug induced

movement disorder, extrapyramidal

MRI, contrast enhanced

MRI, diffusion weighted

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal intensity of basal ganglia

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple system atrophy

muscle spasm, face

myelopathy, hepatic

nausea and vomiting

neurodegeneration with brain iron accumulation

neuroleptic, atypical

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic examination, focal

neurologic signs

neurologic testing

neuronal intranuclear inclusion disease

neuronopathy, sensory

neuropathology, brain

neuropathy, sensory

neuroprotective agents

Niemann-Pick disease

numbness, extremity

obsessive-compulsive disorder

ocular motility, disorders of

old age, neurology of

ophthalmoplegia, progressive external

orthostatic hypotension

pain, increased response

palliative care

paraparesis, spastic

Parkinson disease

Parkinson disease, atypical

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, dystonia with

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, heterogeneity of

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, rapid onset

Parkinson disease, rapid progression

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

Parkinsonism-dementia complex

patient information and support

personality change

pleocytosis of cerebrospinal fluid

portal caval shunt

practice guidelines

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

psychiatric problems in neurologic disorders

psychomotor retardation

psychotic behavior

ptosis, bilateral

pyramidal tract dysfunction

release phenomena

respirations in CNS disease

salivation, excessive

seizure, laughing as manifestation

selective serotonin reuptake inhibitors

serologic testing

shoulder, pain in

single photon emission computed tomography

sleep apnea, obstructive

sleep pathology and physiology

SNCA duplication

speech disorder

speech disorder, childhood

standing difficulty

stereotyped behavior

stiff man syndrome

stimulation, deep brain

striatonigral degeneration

strokelike episodes

synucleinopathy

systemic illness

tandem gait, ataxic

tardive dyskinesia

temporal lobe, atrophy

tick-borne encephalitis

tonic foot response

treatment of neurologic disorder

tremor, postural

tremor, resting

tyrosine hydroxylase deficiency

upgaze, paralysis of

urinary incontinence

vestibular areflexia

viral infection

virtual house calls

visual impairment

visuospatial disturbance

vocal cord paralysis

walking, difficulty with

weakness, progressive

white matter disease

whole genome sequencing

wide based gait

Wolff-Parkinson-White syndrome

word-finding difficulty

Showing articles 1050 to 1100 of 2059 << Previous Next >>

Clinical Presentation and Pharmacological Therapy in Corticobasal Degeneration
Arch Neurol 55:957-961, Kompoliti,K.,et al, 1998

Intellectual Decline After Stroke, The Framingham Study
Stroke 29:805-812, Kase,C.S.,et al, 1998

Practice Styles of US Compared to UK Neurologists
Neurol 50:1661-1668, Vickrey,B.G.,et al, 1998

Postmenopausal Estrogen Use and Parkinson's Disease with and without Dementia
Neurol 50:1141-1143, Marder,K.,et al, 1998

An Unusual Case of Creutzfeldt-Jakob Disease
Neurol 51:617-619, Vingerhoets,F.J.G.,et al, 1998

Acute Delirium After Withdrawal of Amantadine in Parkinson's Disease
Neurol 50:1456-1458, Factor,S.A.,et al, 1998

Dopa-Responsive Dystonia, Some Pieces of the Puzzle are Still Missing
Neurol 50:853-855, Nygaard,T.G.&Wooten,G.F., 1998

Randomized,Double-Blind,Placebo-Controlled Trial of Pergolide in Restless Leg Syndrome
Neurol 51:1599-1602, Earley,C.J.,et al, 1998

Encouraging Initial Response of Restless Legs Syndrome to Pramipexole
Neurol 51:1221-123, Becker,P.M.,et al, 1998

Olfactory Dysfunction in Guamanian ALS,Parkinsonism,and Dementia
Neurol 51:1672-1677, Ahlskog,J.E.,et al, 1998

Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998

Effect of Selegiline on Mortality in Patients with Parkinson's Disease
Neurol 51:825-830, Olanow,C.W.,et al, 1998

Motor, Cognitive, and Behavioral Performance Following Unilateral Ventroposterior Pallidotomy for Parkinson Disease
Arch Neurol 55:1201-1208, Masterman,D.,et al, 1998

Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients
Neurol 51:811-814, Goetz,C.G.,et al, 1998

Ropinirole for the Treatment of Early Parkinson Disease
Arch Neurol 55:1211-1216, Sethi,K.D.,et al, 1998

Long-Term Follow-Up of Levodopa Responsiveness in Generalized Dystonia
Arch Neurol 55:1320-1323, Dewey,R.B.,et al, 1998

Assessment of Motor Function After Stereotactic Pallidotomy
Neurol 50:266-270, Ondo,W.G.,et al, 1998

Tasmar (tolcapone) Labeling Revisions of Package Insert
Roche Laboratories, , 1998

Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998

Drug-Induced Movement Disorders
Neurol Clin 16:125-139, Diederich,N.J. & Goetz,C.G., 1998

Pallidotomy for Generalized Dystonia
Movement Disorders 13:693-698, Ondo,W.G.,et al, 1998

The Risk of Parkinson's Disease with Exposure to Pesticides, Farming, Well Water, and Rural Living
Neurol 50:1346-1350, Gorell,J.M.,et al, 1998

Mortality in People Taking Selegiline:Observational Study
BMJ 317:252-254, Thorogood,M.,et al, 1998

Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998

Investig of PDRG of UK into Excess Mortality Seen/Comb Levodopa & Selegiline Trmt in Pts with Early, Mild Parkinson's Dis
BMJ 316:1191-1196, Ben-Shlomo,Y.,et al, 1998

Functional Neurosurgery for parkinson's Disease, Has Come a Long Way, Though Much Remains Experimental
BMJ 316:1259-1260, Quinn,N.&Bhatia,K., 1998

Pallidotomy for Parkinson's Disease:Hitting the Target
Lancet 351:998-999, Golbe,L.I., 1998

Neuropsychological Consequences of Posteroventral Pallidotomy for the Treatment of Parkinson's Disease
Neurol 51:207-215, Trepanier,L.L.,et al, 1998

Cognitive Functioning After Pallidotomy for Refractory Parkinson's Disease
JNNP 65:150-154, 1481998., Perrine,K.,et al, 1998

Olanzapine Can Worsen Parkinsonism
Neurol 50:1183-1184, Jimenez-Jimenez,F.J.,et al, 1998

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 50:1195-1196, Wolters,E.C.,et al, 1998

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Random, Placebo-Contr Study of Tolcapone in Pts with Fluctuating Parkinson Dis Trtd With Levodopa-Carbidopa
Arch Neurol 55:1089-1095, Adler,C.H.,et al, 1998

Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease
Lancet 351:1221-1222, Nutt,J.G., 1998

Clinical Usefulness of Magnetic Resonance Imaging in Multiple System Atrophy
JNNP 65:65-71, Schrag,A.,et al, 1998

Prediction of Stroke Outcome with Echoplanar Perfusion-and Diffusion-Weighted MRI
Neurol 51:418-426, Barber,P.A.,et al, 1998

Serotonin Syndrome Induced by Transitioning from Phenelzine to Venlafaxine:four Patient Reports
Neurol 51:274-276, Diamond,S.,et al, 1998

Double-Blind Evaluation of Subthalamic Nucleus Deep Brain Stimulation in Advanced Parkinson's Disease
Neurol 51:850-855, Kumar,R.,et al, 1998

Clinicopath Conf
Dementia with Lewy Bodies, Anaplastic Astrocytoma of Right Insular Region, Case 7-1998, NEJM 338:603, 61098., 1998

Decreased Driving Ability in People with Parkinson's Disease
JNNP 64:325-330, Heikkila,V-M.,et al, 1998

An Algorithm (Decision Tree) for the Management of Parkinson's Disease:Trtm Guidelines
Neurol 50:S1-S57, Olanow,C.W.&Koller,W.C., 1998

Visual Fields in Patients with Posterior GPi Pallidotomy
Neurol 50:258-265, Biousse,V.,et al, 1998

Stereotactic pallidotomy for Trtm of Parkinson's Disease, Efficacy & Adverse Effects at 6 Mo in 26 Pts
Neurol 50:434-438, Shannon,K.M.,et al, 1998

Different Predictors of Neurolgoical Worsening in Different Causes of Stroke
Arch Neurol 55:481-486, Yamamoto,H.,et al, 1998

Low Molecular Wt Heparinoid
ORG 10172 (Danaparoid) , & Outcome After Acute Ischemic Stroke, 10172 Acute Stroke Trtm (TOAST) Inve, t, JAMA 1272,1304,1998., 1998

Progressive Supranuclear Palsy, A Survey of the Disease Course
Neurol 50:1637-1647, Santacruz,P.,et al, 1998

Pharmacological Therapy in Progressie Supranuclear Palsy
Arch Neurol 55:1099-1102, Kompoliti,K.,et al, 1998

Thrombolysis-Related Intracranial Hemorrhage, Analysis of 224 Cases from GUSTO-1 Trial with Clin Correl
Stroke 29:563-569, Gebel,J.M.,et al, 1998

Natural History & Survival of 14 Pts with Corticobasal Degeneration Confirmed as Postmortem Exam
JNNP 64:184-189, Wenning,G.K.,et al, 1998

Reduction in Voice Tremor Under Thalamic Stimulation
Neurol 50:796-798, Carpenter,M.A.,et al, 1998

Showing articles 1050 to 1100 of 2059 << Previous Next >>